Haemonetics Corporation (HAE)

Payables turnover

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cost of revenue	US$ in thousands	611,866	617,507	553,563	487,694	472,625
Payables	US$ in thousands	66,999	73,358	63,929	58,371	50,293
Payables turnover		9.13	8.42	8.66	8.36	9.40

March 31, 2025 calculation

Payables turnover = Cost of revenue ÷ Payables
= $611,866K ÷ $66,999K
= 9.13

Haemonetics Corporation's payables turnover ratio has demonstrated some fluctuations over the past few years. In March 2021, the company achieved a payables turnover of 9.40, indicating that it paid its suppliers approximately 9.40 times during that year. However, this ratio decreased to 8.36 in March 2022 and slightly increased to 8.66 in March 2023 before declining to 8.42 in March 2024.

The payables turnover ratio for March 2025 is missing ("—"), which may be due to the unavailability of specific data for that period. Overall, the trend suggests that Haemonetics Corporation has been managing its accounts payable effectively, with a consistency in paying off its obligations to suppliers. The company's ability to efficiently utilize its accounts payable reflects its liquidity and operational efficiency in managing working capital.